Impact of Open Access status on journal metrics in infectious diseases and clinical microbiology – A cross-sectional study - 01/06/24
Highlights |
• | No data are currently available on open access (OA) publication cost and academic impact in infectious diseases (ID). |
• | Evaluating 255 ID journals, the median cost of full OA journals was lower than that of hybrid journals (2000$ vs 3550$). |
• | Full OA journals had lower citation numbers, immediacy index, influence score, and Eigenfactor. |
• | In ID, considerable costs are required for OA publication, limiting the ability of researchers to share their data. |
• | Trying to lower the cost by choosing full OA journal is associated with measures entailing lower quality. |
Abstract |
Introduction |
While Open Access (OA) journals provide free access to articles, they entail high article processing charges (APC), limiting opportunities for young researchers and those from low-middle income countries to publish OA.
Methods |
Cross-sectional study, evaluating APC and academic impact of full OA (FOA) journals in infectious diseases (ID) and clinical microbiology (CM) compared to hybrid journals. Data were collected from Journal Citation Reports and journals’ websites.
Results |
Among 255 journals, median APC was 2850 (interquartile range [IQR] 1325–3654$). Median APC for 120 FOA journals was significantly lower than for 119 hybrid journals (2000, IQR 648–2767$ versus 3550, IQR 2948–4120$, p < 0.001). FOA journals had lower citation numbers and impact metrics compared to hybrid journals.
Conclusion |
While FOA ID/CM journals have lower APCs, they also lower academic impact compared to hybrid journals. These findings highlight the need for reforms in the publication process in view of achieving equitable data dissemination.
Le texte complet de cet article est disponible en PDF.Keywords : Infectious diseases, Open access, Article production fee, LMIC, Publication
Plan
Vol 54 - N° 4
Article 104909- juin 2024 Retour au numéro
Article précédent
- Bronchiolitis 2022–2023: One of the most unexpected outbreaks over this past decade, Nouvelle-Aquitaine, France
- Gaëlle Gault, Laure Meurice, Anais Lamy, Caroline Couturier, Pascal Vilain, Céline Etchetto, Laurent Filleul
- Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward?
- Victor Gerber, Louis Boehn, Marcela Sabou, Antoine Studer, Axel Ursenbach, Yves Hansmann, Raoul Herbrecht, Nicolas Lefebvre, Valérie Letscher-Bru, François Danion
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?